NumerixS Investment Technologies’s GSK GSK Stock Holding History

NumerixS Investment Technologies’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,120	Closed	-$148K	–	1158
2020 Q1	$148K	Buy	+3,120	New	+$166K	0.08%	316
2019 Q3	–	Sell	-5,360	Closed	-$268K	–	1095
2019 Q2	$268K	Buy	+5,360	New	+$269K	0.08%	321
2019 Q1	–	Sell	-2,400	Closed	-$114K	–	1193
2018 Q4	$114K	Buy	+2,400	New	+$118K	0.04%	521
2018 Q3	–	Sell	-9,520	Closed	-$471K	–	1264
2018 Q2	$471K	Buy	+9,520	New	+$479K	0.11%	268
2018 Q1	–	Sell	-3,520	Closed	-$156K	–	1136
2017 Q4	$156K	Buy	+3,520	New	+$163K	0.04%	533
2017 Q3	–	Sell	-7,440	Closed	-$401K	–	1228
2017 Q2	$401K	Buy	7,440 +3,920	+111%	+$209K	0.06%	405
2017 Q1	$186K	Sell	3,520 -27,920	-89%	-$1.42M	0.02%	740
2016 Q4	$1.51M	Buy	+31,440	New	+$1.55M	0.19%	125
2015 Q2	–	Sell	-3,920	Closed	-$226K	–	684
2015 Q1	$226K	Buy	+3,920	New	+$225K	0.04%	511

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NumerixS Investment Technologies's GSK Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of GSK (GSK) in Q2 2020, closing a stake of 3,120 shares — an estimated $148K sold.

NumerixS Investment Technologies first reported a position in GSK in Q1 2015 and held it in 9 quarters. The position peaked at $1.51M in Q4 2016. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

NumerixS Investment Technologies reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 3,120 GSK shares in Q2 2020, an estimated $148K.
NumerixS Investment Technologies first reported a position in GSK in Q1 2015 and held it in 9 quarters.
NumerixS Investment Technologies's GSK position peaked at $1.51M in Q4 2016.
840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.